Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

ColoSeal™ ICD System Safety and Feasibility Study — Stella

Home/Colorectal Cancer/ColoSeal™ ICD System Safety and Feasibility Study

View on ClinicalTrials.gov

Recruiting

Back to Colorectal Cancer trials

ColoSeal™ ICD System Safety and Feasibility Study

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(3 sites)

Armenia

National Center of Oncology after V.A. Fanarjian, Yerevan

Georgia

Israeli-Georgian Medical Research Clinic Healthycore, Tbilisi

Uzbekistan

National Cancer Institute, Tashkent

Key details

Sponsor

Averto Medical, Inc.

Enrollment target

~15 participants

Started

June 2023

Primary completion

June 2026

Age range

18 Years – 70 Years

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.